Further, MBP-426 (Mebiopharm), a liposome loaded with oxaliplatin (L-OHP), was conjugated to transferrin (Tf) for tumor targeting and currently undergoing phase II trials (van der Meel et al., 2013). The gene discussed is TF; the disease is neoplasm.